SMO and cancer: A high-throughput screen for inhibitors of SMO ciliary localization and ciliogenesis led to the identification of two ciliogenesis antagonists that disrupt ciliogenesis, inhibit the activation of the HH pathway, and abrogate the proliferation of basal-cell-carcinoma-like cancer cells (BCC) [194].